Caption Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Hold |
12,676
| – | – | ﹤0.01% | 447 |
|
|
2025
Q1 | $90.1K | Sell |
12,676
-42,324
| -77% | -$301K | ﹤0.01% | 455 |
|
|
2024
Q4 | $641K | Buy |
55,000
+54,100
| +6,011% | +$631K | 0.01% | 258 |
|
|
2024
Q3 | $18.5K | Sell |
900
-5,100
| -85% | -$105K | ﹤0.01% | 409 |
|
|
2024
Q2 | $134K | Sell |
6,000
-9,616
| -62% | -$215K | ﹤0.01% | 303 |
|
|
2024
Q1 | $430K | Buy |
+15,616
| New | +$430K | 0.01% | 225 |
|
|
2023
Q4 | – | Sell |
-500
| Closed | -$15.8K | – | 737 |
|
|
2023
Q3 | $15.8K | Buy |
+500
| New | +$15.8K | ﹤0.01% | 390 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 637 |
|
|
2023
Q1 | – | Sell |
-1,550
| Closed | -$54.1K | – | 675 |
|
|
2022
Q4 | $54.1K | Sell |
1,550
-12,056
| -89% | -$421K | ﹤0.01% | 370 |
|
|
2022
Q3 | $762K | Sell |
13,606
-22,574
| -62% | -$1.26M | 0.01% | 168 |
|
|
2022
Q2 | $1.87M | Buy |
36,180
+31,880
| +741% | +$1.65M | 0.03% | 123 |
|
|
2022
Q1 | $312K | Buy |
4,300
+2,314
| +117% | +$168K | ﹤0.01% | 356 |
|
|
2021
Q4 | $234K | Buy |
+1,986
| New | +$234K | ﹤0.01% | 437 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 794 |
|
|
2021
Q2 | – | Sell |
-37,701
| Closed | -$3.03M | – | 692 |
|
|
2021
Q1 | $3.03M | Buy |
+37,701
| New | +$3.03M | 0.07% | 70 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 551 |
|